Your session is about to expire
← Back to Search
Respiratory Support
SuperNO2VA Et Versus Oxygen Face Mask During Deep Sedation (iOXYGENATE Trial)
N/A
Waitlist Available
Led By Juan Cata, MD
Research Sponsored by Vyaire Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up total duration of procedure and post procedure in pacu
Awards & highlights
No Placebo-Only Group
Summary
This trial compares two methods to help high-risk patients breathe better during procedures. One method uses a nasal mask that pushes air into the nose, and the other uses a facemask that provides extra oxygen. The goal is to see which method is more effective in preventing low oxygen levels.
Eligible Conditions
- Low Oxygen Levels
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ oxygen saturation below 90% for >15 seconds during procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~oxygen saturation below 90% for >15 seconds during procedure
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Hypoxemia
Secondary study objectives
Airway maneuvers
Anesthesiologist Satisfaction
Cardiac Complications
+9 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: SuperNO2VA EtExperimental Treatment1 Intervention
Continuous positive airway pressure with end-tidal CO2 monitoring
Group II: Supplemental Oxygen Face MaskActive Control1 Intervention
Find a Location
Who is running the clinical trial?
Vyaire MedicalLead Sponsor
10 Previous Clinical Trials
1,714 Total Patients Enrolled
M.D. Anderson Cancer CenterOTHER
3,074 Previous Clinical Trials
1,803,435 Total Patients Enrolled
Juan Cata, MDPrincipal InvestigatorM.D. Anderson Cancer Center
5 Previous Clinical Trials
90 Total Patients Enrolled